Jnba Financial Advisors Abb Vie Inc. Transaction History

Jnba Financial Advisors

$980 Million
Q3 2024

A detailed history of Jnba Financial Advisors transactions in Abb Vie Inc. stock. As of the latest transaction made, Jnba Financial Advisors holds 9,097 shares of ABBV stock, worth $1.6 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

9,097

Previous 9,097 -0.0%

Holding current value

$1.6 Million

Previous $1.56 Million 15.13%

% of portfolio

0.18%

Previous 0.16%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 22, 2024	BUY	$154.79 - $180.76 $18,574 - $21,691	120 Added 1.34%	9,097 $1.56 Million
Q1 2024 Apr 26, 2024	SELL	$159.82 - $182.1 $36,918 - $42,065	-231 Reduced 2.51%	8,977 $1.63 Million
Q4 2023 Feb 07, 2024	BUY	$137.6 - $154.97 $9,081 - $10,228	66 Added 0.72%	9,208 $1.43 Million
Q3 2023 Nov 02, 2023	SELL	$133.59 - $154.65 $31,393 - $36,342	-235 Reduced 2.51%	9,142 $1.36 Million
Q2 2023 Aug 03, 2023	BUY	$132.51 - $164.9 $3,975 - $4,947	30 Added 0.32%	9,377 $1.26 Million
Q1 2023 May 01, 2023	SELL	$144.61 - $166.54 $54,373 - $62,619	-376 Reduced 3.87%	9,347 $1.49 Million
Q4 2022 Feb 06, 2023	SELL	$138.31 - $165.87 $44,120 - $52,912	-319 Reduced 3.18%	9,723 $1.57 Million
Q3 2022 Nov 07, 2022	SELL	$134.21 - $153.93 $21,742 - $24,936	-162 Reduced 1.59%	10,042 $1.35 Million
Q2 2022 Jul 22, 2022	BUY	$137.62 - $174.96 $9,771 - $12,422	71 Added 0.7%	10,204 $1.56 Million
Q1 2022 Apr 29, 2022	SELL	$131.98 - $163.75 $74,304 - $92,191	-563 Reduced 5.26%	10,133 $1.64 Million
Q4 2021 Feb 03, 2022	SELL	$107.43 - $135.93 $17,725 - $22,428	-165 Reduced 1.52%	10,696 $1.45 Million
Q1 2021 May 03, 2021	BUY	$102.3 - $112.62 $26,188 - $28,830	256 Added 2.41%	10,861 $1.18 Million
Q4 2020 Jan 25, 2021	BUY	$80.49 - $108.67 $3,541 - $4,781	44 Added 0.42%	10,605 $1.14 Million
Q3 2020 Nov 05, 2020	SELL	$85.91 - $100.83 $4,295 - $5,041	-50 Reduced 0.47%	10,561 $925,000
Q2 2020 Jul 24, 2020	BUY	$73.37 - $98.18 $2,714 - $3,632	37 Added 0.35%	10,611 $1.04 Million
Q1 2020 May 01, 2020	BUY	$64.5 - $97.79 $19,995 - $30,314	310 Added 3.02%	10,574 $806,000
Q3 2019 Nov 01, 2019	SELL	$62.98 - $75.72 $18,264 - $21,958	-290 Reduced 2.75%	10,264 $777,000
Q2 2019 Jul 26, 2019	BUY	$65.7 - $83.98 $19,250 - $24,606	293 Added 2.86%	10,554 $768,000
Q1 2019 May 01, 2019	SELL	$77.14 - $90.79 $3,934 - $4,630	-51 Reduced 0.49%	10,261 $827,000
Q4 2018 Feb 07, 2019	BUY	$77.85 - $96.01 $802,789 - $990,055	10,312 New	10,312 $951,000
Q3 2018 Nov 01, 2018	SELL	$88.91 - $98.84 $904,659 - $1.01 Million	-10,175 Closed	0 $0
Q1 2018 May 07, 2018	SELL	$92.01 - $123.21 $9,201 - $12,321	-100 Reduced 0.97%	10,175 $10.2 Million
Q4 2017 Jan 31, 2018	SELL	$89.56 - $98.21 $51,049 - $55,979	-570 Reduced 5.26%	10,275 $994,000
Q3 2017 Nov 13, 2017	SELL	$69.85 - $89.22 $106,591 - $136,149	-1,526 Reduced 12.34%	10,845 $964,000
Q2 2017 Aug 14, 2017	BUY	N/A	12,371	12,371 $897,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jnba Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Jnba Financial Advisors with notifications on news.

Account

Jnba Financial Advisors Abb Vie Inc. Transaction History